Annual influenza vaccination affects the development of heterosubtypic immunity

Vaccine

Volumn 30, Issue 51, 2012, Pages 7407-7410

  Bodewes, Rogier ^a   Fraaij, Pieter L A ^a,b   Kreijtz, Joost H C M ^a   Geelhoed Mieras, Martina M ^a   Fouchier, Ron A M ^a   Osterhaus, Albert D M E ^a,c   Rimmelzwaan, Guus F ^a,c  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^c ViroClinics Biosciences   (Netherlands)

Author keywords

Children; Influenza; Vaccine

Indexed keywords

INFLUENZA VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AVIAN INFLUENZA VIRUS; CD8+ T LYMPHOCYTE; CELL SPECIFICITY; CONTROLLED STUDY; CROSS REACTION; CYSTIC FIBROSIS; DRUG BLOOD LEVEL; FEMALE; HUMAN; INFLUENZA VACCINATION; INFLUENZA VIRUS A H3N2; INFLUENZA VIRUS A H5N1; MOUSE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; SEASONAL INFLUENZA; VIRUS IMMUNITY; VIRUS INDUCTION;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CHILD; CHILD, PRESCHOOL; CROSS PROTECTION; FEMALE; HUMANS; INFLUENZA VACCINES; LEUKOCYTES, MONONUCLEAR; MALE; MICE; MICE, INBRED C57BL; MODELS, ANIMAL; ORTHOMYXOVIRIDAE INFECTIONS; VACCINATION;

EID: 84870255036     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.04.086     Document Type: Article

References (30)

1. World Health Organization (WHO) Influenza (Seasonal) Fact Sheet No. 211 2009, Available at: www.who.int/mediacentre/factsheets/fs211/en/index.html.
2. Fiore A.E., Shay D.K., Broder K., Iskander J.K., Uyeki T.M., Mootrey G., et al. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008. MMWR Recomm Rep 2008, 57(August (RR-7)):1-60.
3. Usonis V., Anca I., Andre F., Chlibek R., Ivaskeviciene I., Mangarov A., et al. Central European Vaccination Advisory Group (CEVAG) guidance statement on recommendations for influenza vaccination in children. BMC Infect Dis 2010, 10:168.
4. Fraaij P.L., Bodewes R., Osterhaus A.D., Rimmelzwaan G.F. The ins and outs of universal childhood influenza vaccination. Future Microbiol 2011, 6(October):1171-1184.
5. Bodewes R., Kreijtz J.H., Rimmelzwaan G.F. Yearly influenza vaccinations: a double-edged sword?. Lancet Infect Dis 2009, 9(December (12)):784-788.
6. Epstein S.L., Price G.E. Cross-protective immunity to influenza A viruses. Expert Rev Vaccines 2010, 9(November (11)):1325-1341.
7. Grebe K.M., Yewdell J.W., Bennink J.R. Heterosubtypic immunity to influenza A virus: where do we stand?. Microbes Infect 2008, 10(July (9)):1024-1029.
8. Epstein S.L. Prior H1N1 influenza infection and susceptibility of Cleveland Family Study participants during the H2N2 pandemic of 1957: an experiment of nature. J Infect Dis 2006, 193(January (1)):49-53.
9. Cowling B.J., Ng S., Ma E.S., Cheng C.K., Wai W., Fang V.J., et al. Protective efficacy of seasonal influenza vaccination against seasonal and pandemic influenza virus infection during 2009 in Hong Kong. Clin Infect Dis 2010, 51(December (12)):1370-1379.
10. McCaw J.M., McVernon J., McBryde E.S., Mathews JD Influenza: accounting for prior immunity. Science 2009, 325(August (5944)):1071. author reply 72-3.
11. Liang S., Mozdzanowska K., Palladino G., Gerhard W. Heterosubtypic immunity to influenza type A virus in mice. Effector mechanisms and their longevity. J Immunol 1994, 152(February (4)):1653-1661.
12. Epstein S.L., Lo C.Y., Misplon J.A., Lawson C.M., Hendrickson B.A., Max E.E., et al. Mechanisms of heterosubtypic immunity to lethal influenza A virus infection in fully immunocompetent, T cell-depleted, beta2-microglobulin-deficient, and J chain-deficient mice. J Immunol 1997, 158(February (3)):1222-1230.
13. Yewdell J.W., Bennink J.R., Smith G.L., Moss B. Influenza A virus nucleoprotein is a major target antigen for cross-reactive anti-influenza A virus cytotoxic T lymphocytes. Proc Natl Acad Sci U S A 1985, 82(March (6)):1785-1789.
14. Townsend A.R., Skehel J.J. The influenza A virus nucleoprotein gene controls the induction of both subtype specific and cross-reactive cytotoxic T cells. J Exp Med 1984, 160(August (2)):552-563.
15. McMichael A.J., Gotch F.M., Noble G.R., Beare P.A. Cytotoxic T-cell immunity to influenza. N Engl J Med 1983, 309(July (1)):13-17.
16. Bodewes R., Kreijtz J.H., Baas C., Geelhoed-Mieras M.M., de Mutsert G., van Amerongen G., et al. Vaccination against human influenza A/H3N2 virus prevents the induction of heterosubtypic immunity against lethal infection with avian influenza A/H5N1 virus. PLoS One 2009, 4(5):e5538.
17. Bodewes R., Kreijtz J.H., Hillaire M.L., Geelhoed-Mieras M.M., Fouchier R.A., Osterhaus A.D., et al. Vaccination with whole inactivated virus vaccine affects the induction of heterosubtypic immunity against influenza virus A/H5N1 and immunodominance of virus-specific CD8+ T-cell responses in mice. J Gen Virol 2010, 91(July (Pt 7)):1743-1753.
18. Bodewes R., Kreijtz J.H., Geelhoed-Mieras M.M., van Amerongen G., Verburgh R.J., van Trierum S.E., et al. Vaccination against seasonal influenza A/H3N2 virus reduces the induction of heterosubtypic immunity against influenza A/H5N1 virus infection in ferrets. J Virol 2011, 85(March (6)):2695-2702.
19. Bodewes R., Fraaij P.L., Geelhoed-Mieras M.M., van Baalen C.A., Tiddens H.A., van Rossum A.M., et al. Annual vaccination against influenza virus hampers development of virus-specific CD8+ T cell immunity in children. J Virol 2011, 85(November (22)):11995-12000.
20. van Gageldonk P.G., van Schaijk F.G., van der Klis F.R., Berbers G.A. Development and validation of a multiplex immunoassay for the simultaneous determination of serum antibodies to Bordetella pertussis, diphtheria and tetanus. J Immunol Methods 2008, 335(June (1-2)):79-89.
21. Skowronski D.M., De Serres G., Crowcroft N.S., Janjua N.Z., Boulianne N., Hottes T.S., et al. Association between the 2008-09 seasonal influenza vaccine and pandemic H1N1 illness during Spring-Summer 2009: four observational studies from Canada. PLoS Med 2010, 7(4):e1000258.
22. Nelson C.A., France E.K., Shetterly S.M., Glanz J.M. Seasonal influenza vaccination status among children with laboratory evidence of pandemic H1N1 infection. Pediatr Infect Dis J 2011, 30(July (7)):562-565.
23. Hak E., Buskens E., van Essen G.A., de Bakker D.H., Grobbee D.E., Tacken M.A., et al. Clinical effectiveness of influenza vaccination in persons younger than 65 years with high-risk medical conditions: the PRISMA study. Arch Intern Med 2005, 165(February (3)):274-280.
24. He X.S., Holmes T.H., Zhang C., Mahmood K., Kemble G.W., Lewis D.B., et al. Cellular immune responses in children and adults receiving inactivated or live attenuated influenza vaccines. J Virol 2006, 80(December (23)):11756-11766.
25. Hoft D.F., Babusis E., Worku S., Spencer C.T., Lottenbach K., Truscott S.M., et al. Live and inactivated influenza vaccines induce similar humoral responses, but only live vaccines induce diverse T-cell responses in young children. J Infect Dis 2011, 204(September (6)):845-853.
26. Girard M.P., Osterhaus A., Pervikov Y., Palkonyay L., Kieny M.P. Report of the third meeting on influenza vaccines that induce broad spectrum and long-lasting immune responses, World Health Organization, Geneva, Switzerland, 3-4 December 2007. Vaccine 2008, 26(May (20)):2443-2450.
27. Steel J., Lowen A.C., Wang T.T., Yondola M., Gao Q., Haye K., et al. Influenza virus vaccine based on the conserved hemagglutinin stalk domain. MBio 2010, (April (1)).
28. Wang T.T., Tan G.S., Hai R., Pica N., Ngai L., Ekiert D.C., et al. Vaccination with a synthetic peptide from the influenza virus hemagglutinin provides protection against distinct viral subtypes. Proc Natl Acad Sci U S A 2010, 107(44):18979-18984.
29. Soboleski M.R., Gabbard J.D., Price G.E., Misplon J.A., Lo C.Y., Perez D.R., et al. Cold-adapted influenza and recombinant adenovirus vaccines induce cross-protective immunity against pH1N1 challenge in mice. PLoS One 2011, 6(7):e21937.
30. Berthoud T.K., Hamill M., Lillie P.J., Hwenda L., Collins K.A., Ewer K.J., et al. Potent CD8+ T-cell immunogenicity in humans of a novel heterosubtypic influenza A vaccine, MVA-NP+M1. Clin Infect Dis 2011, 52(January (1)):1-7.